Abstract
Understanding the pathogenesis of neuropsychiatric disorders is a substantial challenge for neurobiologists. It has long been hoped that identifying alleles that confer increased risk of such disorders would provide clues for neurobiological investigation. But this quest has been stymied by a lack of validated biological markers for characterizing and distinguishing the different disorders and by the genetic complexity underpinning these diseases. Now, modern genomic technologies have begun to facilitate the discovery of relevant genes.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R. & Walters, E. E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 617–627 (2005).
Kessler, R. C. et al. Prevalence and treatment of mental disorder, 1990 to 2003. N. Engl. J. Med. 352, 2515–2513 (2005).
Murray, C. J. & Lopez, A. D. The Global Burden of Disease (Harvard Univ. Press, 1996).
World Health Organization. World Health Report 2001 (WHO, 2001).
Nestler, E. J., Hyman, S. E. & Malenka, R. J. Molecular Neuropharmacology: Foundation for Clinical Neuroscience 2nd edn (McGraw-Hill, 2008).
Kendler, K. S., Davis, C. G. & Kessler, R. C. The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study. Br. J. Psychiatry 170, 541–548 (1997).
Craddock, N., O'Donovan, M. C. & Owen, M. J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J. Med. Genet. 42, 193–204 (2005).
Hyman, S. E. Can neuroscience be integrated into the DSM-V? Nature Rev. Neurosci. 8, 725–732 (2007).
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edn, text revision (American Psychiatric Association, 2000).
Freitag, C. M. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol. Psychiatry 12, 2–22 (2007).
Sullivan, P. F., Kendler, K. S. & Neale, M. C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60, 1187–1192 (2003).
Merikangas, K. R. & Risch, N. Will the genomics revolution revolutionize psychiatry? Am. J. Psychiatry 160, 625–635 (2003).
Merikangas, K. R. & Risch, N. Genomic priorities and public health. Science 302, 599–601 (2003).
Kendler, K. S., Gatz, M., Gardner, C. O. & Pederson, N. L. A Swedish national twin study of lifetime major depression. Am. J. Psychiatry 163, 109–114, (2006).
Hardy, J. A hundred years of Alzheimer's disease research. Neuron 52, 3–13 (2006).
St. Clair, D. et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336, 13–16 (1990).
Hennah, W. et al. DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol. Psychiatry advance online publication, doi:10.1038/mp.2008.22 (4 March 2008).
Pacione, L. R., Szego, M. J., Ikeda, S., Nishina, P. M. & McInnes, R. R. Progress toward understanding the genetic and biochemical mechanisms of inherited photoreceptor degenerations. Annu. Rev. Neurosci. 26, 657–700 (2003).
Hunter, D. J., Altshuler, D. & Rader, D. J. From Darwin's finches to canaries in the coal mine — mining the genome for new biology. N. Engl. J. Med. 358, 2760–2763 (2008).
Strittmatter, W. J. et al. Apoliprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 1977–1981 (1993).
Edwards, A. O. et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419–421 (2005).
Zeggini, E. et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nature Genet. 40, 638–645 (2008).
Easton, D. F. et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087–1093 (2007).
Ciardiello, F. & Tortora, G. EGFR antagonists in cancer treatment. N. Engl. J. Med. 358, 1160–1174 (2008).
Chobanian, A. V. et al. National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hum. Mol. Genet. 42, 1206–1252 (2003).
Millar, J. K. et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9, 1415–1423 (2000).
Kendler, K. S. & Gardner, C. O. Jr . Boundaries of major depression: an evaluation of DSM-IV criteria. Am. J. Psychiatry 155, 172–177 (1998).
Ferreira, M. A. R. et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genet. 40, 1056–1058 (2008).
O'Donovan, M. C. et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genet. 40, 1053–1055 (2008).
Chahrour, M. & Zoghbi, H. Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422–437 (2007).
Reddy, K. S. Cytogenetic abnormalities and fragile-X syndrome in autism spectrum disorders. BMC Med. Genet. 6, 3–19 (2005).
Lewis, J., Thomas, H., Murphy, K. & Sampson, J. Genotype and psychological phenotype in tuberous sclerosis. J. Med. Genet. 41, 203–207 (2004).
Williams, N. M., O'Donovan, M. C. & Owen, M. J. Chromosome 22 deletion syndrome and schizophrenia. Int. Rev. Neurobiol. 73, 1–27 (2006).
Kobrynski, L. J. & Sullivan, K. E. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370, 1443–1452 (2007).
Veenstra-Vanderweele, J., Christian, S. L. & Cook, E. H. Jr . Autism as a paradigmatic complex genetic disorder. Annu. Rev. Genomics Hum. Genet. 5, 379–405 (2004).
Waring, S. C. & Rosenberg, R. N. Genome-wide association studies in Alzheimer disease. Arch. Neurol. 65, 329–334 (2008).
Farrer, M. J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nature Rev. Genet. 7, 306–318 (2006).
Valdmanis, P. N. & Rouleau, G. A. Genetics of familial amyotrophic lateral sclerosis. Neurology 70, 144–152 (2008).
Walsh, T. et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539–543 (2008).
Xu, B. et al. Strong association of de novo copy number mutations with sporadic schizophrenia. Nature Genet. 40, 880–885 (2008).
The International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455, 237–241 (2008).
Weiss, L. A. et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358, 667–675 (2008).
Morrow, E. M. et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 321, 218–223 (2008).
Redon, R. et al. Global variation in copy number in the human genome. Nature 444, 444–454 (2006).
Gotz, J. & Ittner, L. M. Animal models of Alzheimer's disease and frontotemproal dementia. Nature Rev. Neurosci. 9, 532–544 (2008).
Watase, K. & Zoghbi, H. Y. Modelling brain diseases in mice: the challenges of design and analysis. Nature Rev. Genet. 4, 296–307 (2003).
Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG binding protein 2. Nature Genet. 23, 185–188 (1999).
Egeland, J. A. et al. Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 325, 783–787 (1987).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Additional information
Reprints and permissions information is available at http://www.nature.com/reprints.
Correspondence should be addressed to the author (seh@harvard.edu).
Rights and permissions
About this article
Cite this article
Hyman, S. A glimmer of light for neuropsychiatric disorders. Nature 455, 890–893 (2008). https://doi.org/10.1038/nature07454
Published:
Issue date:
DOI: https://doi.org/10.1038/nature07454
This article is cited by
-
Probiotics and Paraprobiotics: Effects on Microbiota-Gut-Brain Axis and Their Consequent Potential in Neuropsychiatric Therapy
Probiotics and Antimicrobial Proteins (2024)
-
Human nutritional relevance and suggested nutritional guidelines for vitamin A5/X and provitamin A5/X
Nutrition & Metabolism (2023)
-
The neuronal and synaptic dynamics underlying post-inhibitory rebound burst related to major depressive disorder in the lateral habenula neuron model
Cognitive Neurodynamics (2023)
-
Functional patient-derived cellular models for neuropsychiatric drug discovery
Translational Psychiatry (2021)
-
Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks
Molecular Psychiatry (2020)
